Comparing Haloperidol and Olanzapine in Treating Terminal Delirium

Clinical trial NCT04750395 · UNKNOWN

Trial details

NCT number: NCT04750395
Sponsor: HCA Hospice Care
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Delirium Terminal Illness

Start date: 2021-09-01
Primary completion: 2024-05-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.